Yong Yi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Inflammatory Response

Signaling Pathway

Top Venues

Cancer research

Journal of hepatocellular carcinoma

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer research 84 (11) (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy. Cancer research (2024)
Jialei Weng, Zheng Wang, Zhi-Qiu Hu, Wenxin Xu, Jia-Lei Sun, Fu Wang, Qiang Zhou, Shaoqing Liu, Min Xu, Ming-Hao Xu, Dongmei Gao, Ying-Hao Shen, Yong Yi, Yi Shi, Qiong-Zhu Dong, Chenhao Zhou, Ning Ren
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer research 84 (11) (2024)
Pei-Yun Zhou, Cheng Zhou, Wei Gan, Zheng Tang, Bao-Ye Sun, Jin-Long Huang, Gao Liu, Wei-Ren Liu, Meng-Xin Tian, Xi-Fei Jiang, Han Wang, Chen-Yang Tao, Yuan Fang, Wei-Feng Qu, Run Huang, Gui-Qi Zhu, Cheng Huang, Xiu-Tao Fu, Zhen-Bin Ding, Qiang Gao, Jian Zhou, Ying-Hong Shi, Yong Yi, Jia Fan, Shuang-Jian Qiu
Single-cell and spatial architecture of primary liver cancer. Communications biology 6 (1) (2023)
Cheng Zhou, Zhang-Fu Yang, Bao-Ye Sun, Yong Yi, Zheng Wang, Jian Zhou, Jia Fan, Wei Gan, Ning Ren, Shuang-Jian Qiu
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Cheng Zhou, Zhang-Fu Yang, Bao-Ye Sun, Yong Yi, Zheng Wang, Jian Zhou, Jia Fan, Wei Gan, Ning Ren, Shuang-Jian Qiu
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Xuhong Liu, Yong Yi
Sintilimab plus sorafenib: a novel regimen for hepatocellular carcinoma. Immunotherapy 13 (17) (2021)
Xiao-Chun Ni, Yong Yi, Yi-Peng Fu, Xiao-Yan Cai, Gao Liu, Jin-Long Huang, Wei Gan, Jie Xu, Shuang-Jian Qiu
Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection. OncoTargets and therapy 13 (2020)